Plasmafit® Revision Structan® Hip Endoprosthesis Cup

Aesculap

Status

Active, not recruiting

Conditions

Rheumatic Arthritis

Degenerative Osteoarthritis

Osteolysis

Femoral Head Avascular Necrosis

Prosthesis Failure

Arthroplasty Complications

Instability of Prosthetic Joint

Fractures, Hip

Treatments

Device: Plasmafit® Revision Structan®

Study type

Observational

Funder types

Industry

Identifiers

NCT04255966

AAG-O-H-1821

Details and patient eligibility

About

The aim of this observational study is to collect clinical and radiological results of the new Plasmafit® Revision Structan® Hip Endoprosthesis Cup in a standard patient population and when used in routine clinical practice.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

Indication for the cementless Plasmafit® Revision Structan® Hip Endoprosthesis Cup (primary and revision cases, with bone conditions typically demanding a press-fit revision cup)
Written informed consent
Cases where a press-fit cup fixation is possible

Exclusion Criteria

Patients < 18 years
Pregnant patients
Patients not able to comply with the study demands, i.e. follow-up visits (mentally or physically)
Patient has an infection in the hip joint region